Healthcare

Shenzhen Roumai Regenerative Medicine Technology Co., Ltd. was established on November 22, 2021.

Shengbao Biotechnology Co., Ltd. was established in 2023 and is headquartered in Shenzhen, China. The company is committed to developing innovative live bacterial drugs, utilizing gene circuits and precise regulation of gene and payload expression to meet the treatment needs of various types of diseases.

Signor Biotech was founded by a research team from Tsinghua University, combining cutting-edge medical and engineering technologies to highly restore the physiological state of maternal tissues and form "micro organs" (i.e. organoids) composed of multiple cell types.

We founded Innorna in 2019, firmly believing that mRNA can achieve goals that existing treatment methods cannot achieve. From day one, we built a proprietary platform from scratch - a well-designed lipid library containing over 100000 ionizable lipid structures, extensively screened through non-human primate studies, and rigorously synthesized and optimized experimental designs for the target LNP delivery system.